Verapamil as a culprit of palbociclib toxicity.

Author: GowartyJasmine L, HerringtonJon D

Paper Details 
Original Abstract of the Article :
A promising drug, palbociclib, received accelerated approval as a first line treatment when used with the aromatase inhibitor, letrozole, for postmenopausal women with hormone receptor positive advanced or metastatic breast cancer. We report a case of a patient who presented with febrile neutropenia...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1177/1078155218761798

データ提供:米国国立医学図書館(NLM)

Verapamil: A Potential Culprit in Palbociclib Toxicity?

This case report explores a potential drug interaction between [palbociclib], a promising anti-cancer drug, and [verapamil], a calcium channel blocker. The authors describe a patient who experienced severe adverse effects while taking both medications.

A Complex Landscape of Drug Interactions

The patient presented with [febrile neutropenia, grade 3 stomatitis, periorbital edema, and transaminitis] while on palbociclib and verapamil. These adverse effects resolved upon discontinuation of verapamil, suggesting a potential interaction between the two drugs.

Navigating the Drug Interaction Desert

This case report highlights the complexity of drug interactions, emphasizing the importance of careful monitoring and awareness of potential interactions. Just as a camel must navigate a desert landscape with its diverse terrain, healthcare professionals must be mindful of the potential for drug interactions, ensuring patient safety and optimal treatment outcomes.

Dr. Camel's Conclusion

This case report serves as a reminder that the desert of drug interactions can be treacherous and unpredictable. Healthcare professionals must approach drug therapy with a cautious and vigilant mindset, carefully considering potential interactions and ensuring the safety of their patients.

Date :
  1. Date Completed 2019-04-24
  2. Date Revised 2019-04-24
Further Info :

Pubmed ID

29523051

DOI: Digital Object Identifier

10.1177/1078155218761798

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.